161 related articles for article (PubMed ID: 36053937)
1. Genomic and biological aspects of resistance to selective poly(ADP-ribose) glycohydrolase inhibitor PDD00017273 in human colorectal cancer cells.
Tsuda K; Kurasaka C; Ogino Y; Sato A
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1709. PubMed ID: 36053937
[TBL] [Abstract][Full Text] [Related]
2. Dysfunction of poly (ADP-ribose) glycohydrolase suppresses osteoclast differentiation in RANKL-stimulated RAW264 cells.
Sasaki Y; Nakatsuka R; Inoue A; Inouchi T; Masutani M; Nozaki T
Biochem Biophys Res Commun; 2024 Jan; 692():149309. PubMed ID: 38048727
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Poly (ADP-Ribose) Glycohydrolase Accelerates Osteoblast Differentiation in Preosteoblastic MC3T3-E1 Cells.
Sasaki Y; Nakatsuka R; Inouchi T; Masutani M; Nozaki T
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563432
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death.
Ying W; Sevigny MB; Chen Y; Swanson RA
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12227-32. PubMed ID: 11593040
[TBL] [Abstract][Full Text] [Related]
5. ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose).
Niere M; Mashimo M; Agledal L; Dölle C; Kasamatsu A; Kato J; Moss J; Ziegler M
J Biol Chem; 2012 May; 287(20):16088-102. PubMed ID: 22433848
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.
Feng X; Koh DW
Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695
[TBL] [Abstract][Full Text] [Related]
7. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase.
Slade D; Dunstan MS; Barkauskaite E; Weston R; Lafite P; Dixon N; Ahel M; Leys D; Ahel I
Nature; 2011 Sep; 477(7366):616-20. PubMed ID: 21892188
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: A comparison with the PARP1/2/3 inhibitor olaparib.
Gravells P; Neale J; Grant E; Nathubhai A; Smith KM; James DI; Bryant HE
DNA Repair (Amst); 2018 Jan; 61():25-36. PubMed ID: 29179156
[TBL] [Abstract][Full Text] [Related]
9. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
[TBL] [Abstract][Full Text] [Related]
10. PARG has a robust endo-glycohydrolase activity that releases protein-free poly(ADP-ribose) chains.
Pourfarjam Y; Kasson S; Tran L; Ho C; Lim S; Kim IK
Biochem Biophys Res Commun; 2020 Jun; 527(3):818-823. PubMed ID: 32439163
[TBL] [Abstract][Full Text] [Related]
11. Disrupted ADP-ribose metabolism with nuclear Poly (ADP-ribose) accumulation leads to different cell death pathways in presence of hydrogen peroxide in procyclic Trypanosoma brucei.
Schlesinger M; Vilchez Larrea SC; Haikarainen T; Narwal M; Venkannagari H; Flawiá MM; Lehtiö L; Fernández Villamil SH
Parasit Vectors; 2016 Mar; 9():173. PubMed ID: 27007296
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly(ADP-ribose) glycohydrolase null mice.
Cozzi A; Cipriani G; Fossati S; Faraco G; Formentini L; Min W; Cortes U; Wang ZQ; Moroni F; Chiarugi A
J Cereb Blood Flow Metab; 2006 May; 26(5):684-95. PubMed ID: 16177811
[TBL] [Abstract][Full Text] [Related]
13. New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase.
Tanuma S; Sato A; Oyama T; Yoshimori A; Abe H; Uchiumi F
Curr Protein Pept Sci; 2016; 17(7):668-682. PubMed ID: 27817743
[TBL] [Abstract][Full Text] [Related]
14. Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer.
Tanuma SI; Shibui Y; Oyama T; Uchiumi F; Abe H
Biochem Pharmacol; 2019 Sep; 167():163-172. PubMed ID: 31176615
[TBL] [Abstract][Full Text] [Related]
15. Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase.
Gravells P; Grant E; Smith KM; James DI; Bryant HE
DNA Repair (Amst); 2017 Apr; 52():81-91. PubMed ID: 28254358
[TBL] [Abstract][Full Text] [Related]
16. Roles of poly(ADP-ribose) glycohydrolase in DNA damage and apoptosis.
Feng X; Koh DW
Int Rev Cell Mol Biol; 2013; 304():227-81. PubMed ID: 23809438
[TBL] [Abstract][Full Text] [Related]
17. PARG Inhibitors and Functional PARG Inhibition Models.
Sasaki Y; Hozumi M; Fujimori H; Murakami Y; Koizumi F; Inoue K; Masutani M
Curr Protein Pept Sci; 2016; 17(7):641-653. PubMed ID: 27817742
[TBL] [Abstract][Full Text] [Related]
18. A nonradiometric, high-throughput assay for poly(ADP-ribose) glycohydrolase (PARG): application to inhibitor identification and evaluation.
Putt KS; Hergenrother PJ
Anal Biochem; 2004 Oct; 333(2):256-64. PubMed ID: 15450800
[TBL] [Abstract][Full Text] [Related]
19. Preferential perinuclear localization of poly(ADP-ribose) glycohydrolase.
Winstall E; Affar EB; Shah R; Bourassa S; Scovassi IA; Poirier GG
Exp Cell Res; 1999 Sep; 251(2):372-8. PubMed ID: 10471322
[TBL] [Abstract][Full Text] [Related]
20. PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment.
Johnson S; Karpova Y; Guo D; Ghatak A; Markov DA; Tulin AV
BMC Cancer; 2022 May; 22(1):557. PubMed ID: 35585513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]